Actively Recruiting
Randomized, Double-blind Trial of ElectraRx Mindfulness tDCS System for Adults with Major Depressive Disorder
Led by Soterix Medical · Updated on 2026-10-19
25
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness of combining transcranial direct current stimulation tDCS with mindfulness techniques delivered remotely via telemedicine in adults diagnosed with unipolar depression. This study involves 25 participants and aims to understand how this combined approach may impact depressive symptoms. It is a randomized, double-blind, sham-controlled trial sponsored by Soterix Medical. Participants will be assigned to one of two groups one receiving active tDCS along with audio mindfulness instruction and music, and the other receiving sham placebo electrical stimulation combined with the same mindfulness audio guidance. The study uses a parallel-arm design to compare these interventions over the course of treatment. The primary treatment period includes assessments at Week 4 and Week 7. During the study, participants will complete various assessments including the Hamilton Depression Rating Scale HDRS, Quick Inventory of Depressive Symptomatology-Self Report QIDS-SR, Clinical Global Impression scales, Sheehan Disability Scale, and Montgomery-Asburg Depression Rating Scale. These evaluations occur at multiple time points from baseline through Week 13. Safety and blinding integrity will also be monitored. The total study participation lasts around 13 weeks, with regular remote monitoring and questionnaires to track depressive symptoms and overall functioning.
CONDITIONS
Brief Title
Transcranial Direct Current Stimulation for Depression
Research Team
P
Paul Thomas Researcher
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here